Class Central is learner-supported. When you buy through links on our site, we may earn an affiliate commission.

Coursera

Equity Valuation for Pharmaceutical Companies

EDUCBA via Coursera

Overview

Google, IBM & Meta Certificates — All 10,000+ Courses at 40% Off
One annual plan covers every course and certificate on Coursera. 40% off for a limited time.
Get Full Access
Master pharma stock analysis, financial modeling, and equity valuation techniques used by professional equity research analysts. Learn how to evaluate pharmaceutical companies, build financial projections, and estimate intrinsic stock value using real-world financial data. This course provides a practical, step-by-step approach to equity research in the pharmaceutical sector through the real-world case study of Claris Lifesciences. You’ll explore pharma industry dynamics, understand injectables and infusion markets, and learn how business models influence financial performance and investment potential. Through structured lessons and hands-on financial analysis, you’ll examine income statements, identify cost drivers, forecast financial performance, and build valuation models used in professional equity research. The course also covers advanced finance concepts including beta calculation, Weighted Average Cost of Capital (WACC), free cash flow analysis, and discounted cash flow (DCF) valuation techniques. A unique feature of this course is its strong focus on practical application rather than theory alone. By linking financial statements with forecasting and valuation frameworks, learners gain real-world analytical skills used in investment banking, equity research, and financial analysis roles. By the end of the course, you’ll be able to independently analyze pharmaceutical companies, estimate intrinsic stock value, interpret investment opportunities, and make informed equity investment decisions with confidence.

Syllabus

  • Foundations of Claris Lifesciences & Pharma Industry
    • This module introduces learners to Claris Lifesciences, the pharmaceutical industry structure, and core financial concepts, enabling them to understand business dynamics, product segments, and the fundamentals of financial statements essential for equity research.
  • Deep Dive into Financial Analysis & Projections
    • This module focuses on detailed financial analysis, including income statement evaluation, cost drivers, and forecasting techniques, enabling learners to build accurate financial projections for valuation purposes.
  • Valuation & Investment Decision Making
    • This module covers advanced valuation techniques, including cash flow modeling, cost of capital, and equity valuation, enabling learners to determine intrinsic value and make informed investment decisions.

Taught by

EDUCBA

Reviews

Start your review of Equity Valuation for Pharmaceutical Companies

Never Stop Learning.

Get personalized course recommendations, track subjects and courses with reminders, and more.

Someone learning on their laptop while sitting on the floor.